Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1987 2
1988 1
1989 2
1990 5
1991 7
1992 3
1994 4
1995 3
1996 2
1997 2
1999 1
2001 1
2004 2
2007 2
2009 2
2010 1
2011 2
2012 1
2013 1
2014 3
2016 3
2017 7
2018 4
2019 1
2020 3
2021 6
2022 11
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib versus methotrexate in rheumatoid arthritis.
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators. Lee EB, et al. N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476. N Engl J Med. 2014. PMID: 24941177 Free article. Clinical Trial.
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group. Nash P, et al. Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24. Lancet. 2017. PMID: 28551073 Clinical Trial.
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD; SPIRIT-P1 Study Group. Mease PJ, et al. Ann Rheum Dis. 2017 Jan;76(1):79-87. doi: 10.1136/annrheumdis-2016-209709. Epub 2016 Aug 23. Ann Rheum Dis. 2017. PMID: 27553214 Free PMC article. Clinical Trial.
Three-dimensional ultrafast charge-density-wave dynamics in CuTe.
Nhat Quyen N, Tzeng WY, Hsu CE, Lin IA, Chen WH, Jia HH, Wang SC, Liu CE, Chen YS, Chen WL, Chou TL, Wang IT, Kuo CN, Lin CL, Wu CT, Lin PH, Weng SC, Cheng CM, Kuo CY, Tu CM, Chu MW, Chang YM, Lue CS, Hsueh HC, Luo CW. Nhat Quyen N, et al. Among authors: lue cs. Nat Commun. 2024 Mar 16;15(1):2386. doi: 10.1038/s41467-024-46615-y. Nat Commun. 2024. PMID: 38493205 Free PMC article.
High-frequency rectifiers based on type-II Dirac fermions.
Zhang L, Chen Z, Zhang K, Wang L, Xu H, Han L, Guo W, Yang Y, Kuo CN, Lue CS, Mondal D, Fuji J, Vobornik I, Ghosh B, Agarwal A, Xing H, Chen X, Politano A, Lu W. Zhang L, et al. Among authors: lue cs. Nat Commun. 2021 Mar 11;12(1):1584. doi: 10.1038/s41467-021-21906-w. Nat Commun. 2021. PMID: 33707448 Free PMC article.
Tip-Mediated Bandgap Tuning for Monolayer Transition Metal Dichalcogenides.
Lin MK, Chen GH, Ho CL, Chueh WC, Hlevyack JA, Kuo CN, Fu TY, Lin JJ, Lue CS, Chang WH, Takagi N, Arafune R, Chiang TC, Lin CL. Lin MK, et al. Among authors: lue cs. ACS Nano. 2022 Sep 27;16(9):14918-14924. doi: 10.1021/acsnano.2c05841. Epub 2022 Aug 29. ACS Nano. 2022. PMID: 36036754
89 results